Co-Authors
This is a "connection" page, showing publications co-authored by Tom Luedde and Matthias Lutterbeck.
Connection Strength
0.239
-
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg Health Eur. 2021 Sep; 8:100164.
Score: 0.239
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.